Orlando, FL
The future of cell and gene therapy is here: Ncardia’s innovative iPSC-derived platforms, built for consistency, scale and clinical translation. From discovery through development, we help turn iPSC science into real-world therapies.
Meet our team at the Cell & Gene Therapy Summit to explore how our solutions support GMP-compliant manufacturing, accelerate preclinical programs and improve therapeutic outcomes.
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.
Learn More About CGT Summit 2025